Articles

The U.S. Food and Drug Administration (FDA) has approved omega-3 acid ethyl esters (Omacor®) for the treatment of hypertriglyceridemia.

Hypertensive patients taking a combination of an ACE inhibitor and a calcium channel blocker are much less likely to experience an MI or stroke than are those on a beta-blocker and diuretic.

Stimulates the metabolism of body fat, to help patients lose an average of 6.2 pounds over 12 weeks.

May offer explanation for less type 2 diabetes in white population.

The risk of cardiovascular mortality was similar in patients with and without the metabolic syndrome.

Leucine, an essential amino acid found eggs, provides a weight loss advantage during dieting by helping to reduce loss of lean tissue, promote loss of body fat, and stabilize blood glucose levels.

Differences in the inflammation and cytokine profile between COPD and asthma might explain why COPD, but not asthma, is associated with increased risk of type 2 diabetes.

There is a greater risk of CHD in women with type 2 diabetes.

On rare occasions, initiation of the thiazolidinedione rosiglitazone may cause a profound decrease in HDL cholesterol and apoA1, with a concomitant increase in fasting triglycerides.

Diabetics with mental disorders do not have as good blood sugar control as diabetics without mental illness and are more likely to suffer one or more diabetes complication.